Viral-Cancer Molecular Mimicry Atlas
Common cold virus antibodies accidentally target hepatocellular carcinoma via molecular mimicry with ASPH — revealing that prior viral infection history may create natural cancer protection and that viral epitopes could be engineered into therapeutic cancer vaccines.
Viral-Cancer Molecular Mimicry Atlas
Common cold virus antibodies accidentally target hepatocellular carcinoma via molecular mimicry with ASPH — revealing that prior viral infection history may create natural cancer protection and that viral epitopes could be engineered into therapeutic cancer vaccines.
Create a curated, publicly accessible atlas of confirmed and candidate cases of molecular mimicry between viral epitopes and cancer antigens — where antibodies or T cells generated against a virus cross-react with a tumor protein. Each entry would document the viral epitope, the cancer antigen it resembles, the cancer type, the immune mechanism (antibody ADCC, CTL, etc.), the sequence homology, and evidence quality (confirmed vs. computational prediction).
The atlas would include a computational tool that allows researchers to input a viral epitope or cancer neoantigen and query it for known or predicted mimicry with cancer or pathogen proteins. This would support cancer vaccine design by identifying viral-derived sequences that could be leveraged to generate anti-tumor immunity without the challenge of creating de novo tumor antigens.
This is a genuinely underexplored area. The CE1-ASPH discovery suggests that human populations may already carry natural anti-tumor immunity acquired through routine infections — and that this immunity varies by infection history, potentially explaining some geographic and demographic patterns in cancer incidence. A dedicated atlas would help researchers systematically mine this phenomenon rather than encountering it serendipitously, and could directly inform development of viral-epitope-based cancer vaccines.
Who Is This For?
Cancer vaccine developers, tumor immunologists, and epidemiologists studying the intersection of infection history and cancer incidence.
Skills & Tools Needed
- Bioinformatics (sequence alignment, epitope prediction tools)
- Immunology knowledge (antibody cross-reactivity, ADCC)
- Database design and web development
- Literature curation for molecular biology
- Python/Biopython for sequence homology analysis
Feasibility
medium — The core database and sequence analysis tool are buildable, but gathering high-quality curated entries requires both computational expertise and deep literature knowledge across virology and cancer immunology.
Inspired by: Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinoma
